Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
Background: Currently, many COVID-19 vaccine candidates are being developed to end the pandemic; however, immunosuppressed cancer patients have been excluded from the participating criteria. It is important that they are able to examine their options for achieving immunity against COVID-19. Purpose:...
Guardado en:
Autores principales: | I Dewa Agung Panji Dwipayana, I Dewa Ayu Agung Diah Sutarini |
---|---|
Formato: | article |
Lenguaje: | EN ID |
Publicado: |
Universitas Airlangga
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1e02e44d14e4d388e5806a9bfb666a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COVID-19 and BCG vaccine: is there a link?
por: I. V. Lyadova, et al.
Publicado: (2020) -
The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia
por: Rivaldo Steven Heriyanto, et al.
Publicado: (2021) -
Sudden sensorineural hearing loss after COVID-19 vaccination
por: Junhui Jeong, et al.
Publicado: (2021) -
Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain
por: Ignacio Barandalla, et al.
Publicado: (2021) -
The impact of vaccination status on importation of COVID-19 among international travellers
por: Paul Ronksley, et al.
Publicado: (2021)